Journal Guide

Transfusion Clinique et Biologique publishes original papers, general reviews, clinical cases, letters to the editor and editorials concerning transfusion activity in all its scientific and medical aspects.
Articles in English are also accepted.
In the CME section, update articles are published, together with self-evaluations and litterature reviews.

Transfusion Medicine publishes articles on transfusion medicine in its widest context, including blood transfusion practice (blood procurement, pharmaceutical, clinical, scientific, computing and documentary aspects), immunohaematology, immunogenetics, histocompatibility, medico-legal applications, and related molecular biology and biotechnology. In addition to original articles, which may include brief communications and case reports, the journal contains a regular educational section (based on invited reviews and state-of-the-art reports), technical section (including quality assurance and current practice guidelines), leading articles, letters to the editor, occasional historical articles and signed book reviews. Some lectures from Society meetings that are likely to be of general interest to readers of the Journal may be published at the discretion of the Editor and subject to the availability of space in the Journal.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/623385/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

This journal is devoted to all areas of transfusion medicine. These include the quality and security of blood products, therapy with blood components and plasma derivatives, transfusion-related questions in transplantation, stem cell manipulation, therapeutic and diagnostic problems of hemostasis, immunohematological investigations, and legal aspects of the production of blood products as well as hemotherapy. Both comprehensive reviews and primary publications that detail the newest work in transfusion medicine and hemotherapy promote the international exchange of knowledge within these disciplines. Consistent with this goal, continuing clinical education is also specifically addressed.

Transfusion and Apheresis Science brings comprehensive and up-to-date information to physicians and health care professionals involved in the rapidly changing fields of transfusion medicine, hemostasis and apheresis. The journal presents original articles relating to scientific and clinical studies in the areas of immunohematology, transfusion practice, bleeding and thrombotic disorders and both therapeutic and donor apheresis including hematopoietic stem cells. Topics covered include the collection and processing of blood, compatibility testing and guidelines for the use of blood products, as well as screening for and transmission of blood-borne diseases. All areas of apheresis - therapeutic and collection - are also addressed. We would like to specifically encourage allied health professionals in this area to submit manuscripts that relate to improved patient and donor care, technical aspects and educational issues. Transfusion and Apheresis Science features a "Theme" section which includes, in each issue, a group of papers designed to review a specific topic of current importance in transfusion and hemostasis for the discussion of topical issues specific to apheresis and focuses on the operators' viewpoint. Another section is "What's Happening" which provides informal reporting of activities in the field. In addition, brief case reports and Letters to the Editor, as well as reviews of meetings and events of general interest, and a listing of recent patents make the journal a complete source of information for practitioners of transfusion, hemostasis and apheresis science. Immediate dissemination of important information is ensured by the commitment of Transfusion and Apheresis Science to rapid publication of both symposia and submitted papers.

Translational Neurodegeneration is a open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. It aims to provide an forum for international researchers and practitioners to discuss all areas of neurodegenerative diseases including epidemiology, etiology, pathogenesis, diagnosis, management and prevention, as well as their molecular, biochemical and physiological aspects. Our goal is to close the gap between basic research and clinical work in neurodegeneration.Topics of interest include but are not limited to the following areas of neurodegenerative diseases: Epidemiology and pathogenesisResearch into diagnosis and preventionResearch into the diease pathogenesis Development of new drugs and cell therapyDrug delivery RehabilitationBy offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration aims to create a novel interface between the fields of basic medical research, translational research and clinical research into Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease, and other related neurodegenerative diseases. It offers the opportunity for basis scientists, clinicians and physician-scientists to publish their research and clinical trials in a journal which is applicable to their specific field.

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.

Translational Psychiatry is a sister journal to the well-established and number-one journal in psychiatry, Molecular Psychiatry*, but explores the more translational area between the research in neuroscience and conceptually novel treatments. The editorial team is led by Julio Licinio, MD, and includes a highly respected international editorial board. Together, the Translational Psychiatry editorial team and NPG look to further define and shape the field of psychiatry and neuroscience.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/709553/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Topics published in Translational Research in Anatomy include anatomy in all of its aspects, especially those that have application to other scientific disciplines including the health sciences:
• gross anatomy
• neuroanatomy
• histology
• immunohistochemistry
• comparative anatomy
• embryology
• molecular biology
• microscopic anatomy
• forensics
• imaging/radiology
• medical education

Priority will be given to studies that clearly articulate their relevance to the broader aspects of anatomy and how they can impact patient care. Strengthening the ties between morphological research and medicine will foster collaboration between anatomists and physicians. Therefore, Translational Research in Anatomy will serve as a platform for communication and understanding between the disciplines of anatomy and medicine and will aid in the dissemination of anatomical research.

The journal accepts the following article types:
1. Review articles
2. Original research papers
3. New state-of-the-art methods of research in the field of anatomy including imaging, dissection methods, medical devices and quantitation
4. Education papers (teaching technologies/methods in medical education in anatomy)
5. Commentaries
6. Letters to the Editor
7. Selected conference papers

All papers should be submitted in English and must be original work that is unpublished and not under consideration by another journal. An international Editorial Board and reviewers from the anatomical disciplines guarantee a rapid review of your paper within two to three weeks after submission.

Keywords:
Anatomy, neuroanatomy, developmental, biology, surgery, medicine, health care, histology, embryology, translational research, morphology, imaging, radiology, science, integration, molecular biology, basic science, forensics, MRI, 3D imaging

Translational Stroke Research covers basic, translational, and clinical studies. The Journal emphasizes novel approaches in order to help translate scientific discoveries from basic stroke research into the development of new strategies for prevention, assessment, treatment, and repair after stroke and other forms of neurotrauma. Translational Stroke Research focuses on translational research and is relevant to both basic scientists and physicians, including but not restricted to neuroscientists, vascular biologists, neurologists, neuroimagers, and neurosurgeons. The Journal provides an interactive forum for the dissemination of original research articles, review articles, research reports, letters, comments, and research protocols, in stroke and stroke related areas. Its distinguished editorial board is made up of leading stroke researchers and physicians from North America, Europe, and Asia.

CALL FOR PAPERS: 'Phenotypic Transformation of Smooth Muscle in Cerebrovascular Disease'
Guest editor: William

Please bookmark this URL: http://www.elsevier.com/locate/trim

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservices author services .

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/620925/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Transplant Infectious Disease has been established as a forum for presenting the most current information on the prevention and treatment of infection complicating organ and bone marrow transplantation. The point of view of the journal is that infection and allograft rejection (or graft-versus-host disease) are closely intertwined, and that advances in one area will have immediate consequences on the other. The interaction of the transplant recipient with potential microbial invaders, the impact of immunosuppressive strategies on this interaction, and the effects of cytokines, growth factors, and chemokines liberated during the course of infections, rejection, or graft-versus-host disease are central to the interests and mission of this journal. Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of transplantation to clinicians and scientists involved in bone marrow, kidney, liver, heart, lung, intestinal, and pancreatic transplantation. The infectious disease consequences and concerns regarding innovative transplant strategies, from novel immunosuppressive agents to xenotransplantation, are very much a concern of this journal. In addition, this journal feels a particular responsibility to inform primary care practitioners in the community, who increasingly are sharing the responsibility for the care of these patients, of the special considerations regarding the prevention and treatment of infection in transplant recipients. As exemplified by the international editorial board, articles are sought throughout the world that address both general issues and those of a more restricted geographic import. Transplant Infectious Disease includes state-of-the-art review articles on important subjects, the results of clinical investigation, interesting case reports, and two recurring features: a clinical-pathologic conference and reviews of the basic science foundation of transplant infectious disease. Subjects covered include specific infections, the epidemiology of important infections, the interaction among immunosuppression and infection exposure, the diagnosis of specific infection, pathogenesis, and clinical management. Both basic science and clinical articles are featured. Where controversy exists, both sides of an issue are presented. This journal is meant to serve the needs of all clinicians and scientists involved in the study and care of organ and bone marrow transplant recipients.